Trending
- Europe’s Auto Industry, Lawmakers Seek To Thwart EV Monopoly
- Is Oracle Or Palantir The Smarter AI Stock To Buy?
- Broadcom Stock Rises 90% In 6 Months – What’s Fueling The Rally?
- Strong And Rising: Halozyme Therapeutics Stock May Have More Upside
- The 5% Driving Health Costs That Other VCs Overlook
- Auto Industry Forecast: Strong 2025 Gives Way To Weak 2026
- 7 Digital Skills Every Professional Needs In 2025 (beyond Just Coding)
- Why Mental Health Belongs At The Center Of Sustainability Strategy
Friday, October 10
Money
The 90.4% change in Broadcom stock from 4/12/2025 to 10/9/2025 was mainly driven by a 71.0% change in the company’s Net Income Margin (%).
Halozyme Therapeutics stock is a solid choice to leverage the current momentum. It offers strong margins, low-debt capital structure, reasonable valuation, and momentum.
These stocks offer strong market positions, robust financials and sustainable dividend practices. See which dividend stocks you should check out in October 2025.
Taxpayers with FBAR penalty issues must monitor the Sagoo case, a landmark ruling giving jury trial rights in IRS FBAR willful penalty cases. Assert early in IRS audits.
Difficulties in technology projects aren’t unusual, but the problems with artificial intelligence applications are much larger than traditional.
These non-tech, non-social media equities are stuck in sectors greatly affected by consumer expectations for inflation.
“Tax strategy isn’t a cost, it’s a wealth vehicle,” says Ashia Thompson, founder of Top Tier Accounting in Dubai, United Arab Emirates.
Dine Brands CEO took $25M while shareholders lost 70%. Franchisees struggle, investors suffer. Why alignment is key to saving Applebee’s and IHOP.
Prisoners use cell phones smuggled in by drones to perpetrate jury duty scams and court appearance scams.
Mobile Apps
© 2025 The Money Times. All rights reserved